- Home
- WLKP vs NAGE Comparison
WLKP vs NAGE Comparison
Compare WLKP & NAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WLKP
- NAGE
- Stock Information
- Founded
- WLKP 2014
- NAGE 1999
- Country
- WLKP United States
- NAGE United States
- Employees
- WLKP N/A
- NAGE N/A
- Industry
- WLKP Major Chemicals
- NAGE Medicinal Chemicals and Botanical Products
- Sector
- WLKP Industrials
- NAGE Health Care
- Exchange
- WLKP Nasdaq
- NAGE Nasdaq
- Market Cap
- WLKP 739.3M
- NAGE 766.4M
- IPO Year
- WLKP 2014
- NAGE N/A
- Fundamental
- Price
- WLKP $20.06
- NAGE $7.41
- Analyst Decision
- WLKP
- NAGE Strong Buy
- Analyst Count
- WLKP 0
- NAGE 3
- Target Price
- WLKP N/A
- NAGE $17.00
- AVG Volume (30 Days)
- WLKP 54.9K
- NAGE 1.3M
- Earning Date
- WLKP 10-30-2025
- NAGE 11-04-2025
- Dividend Yield
- WLKP 9.40%
- NAGE N/A
- EPS Growth
- WLKP N/A
- NAGE N/A
- EPS
- WLKP 1.49
- NAGE 0.22
- Revenue
- WLKP $1,101,803,000.00
- NAGE $116,303,000.00
- Revenue This Year
- WLKP $3.27
- NAGE $28.91
- Revenue Next Year
- WLKP $13.98
- NAGE $20.89
- P/E Ratio
- WLKP $13.43
- NAGE $34.43
- Revenue Growth
- WLKP N/A
- NAGE 35.90
- 52 Week Low
- WLKP $19.75
- NAGE $3.39
- 52 Week High
- WLKP $25.04
- NAGE $14.69
- Technical
- Relative Strength Index (RSI)
- WLKP 31.97
- NAGE 37.17
- Support Level
- WLKP $19.75
- NAGE $7.20
- Resistance Level
- WLKP $20.92
- NAGE $7.59
- Average True Range (ATR)
- WLKP 0.34
- NAGE 0.38
- MACD
- WLKP -0.07
- NAGE 0.04
- Stochastic Oscillator
- WLKP 18.09
- NAGE 58.50
About WLKP Westlake Chemical Partners LP Common Units representing limited partner interests
Westlake Chemical Partners LP is a part of the chemical industry in the United States. Its operations are conducted through OpCo, it acquires and develops ethylene production facilities, which convert ethane into ethylene. OpCo sells ethylene and its co-products such as propylene, crude butadiene, pyrolysis gasoline, and hydrogen to Westlake and other customers located in the United States. Its assets include three ethylene production facilities in Calvert City, Kentucky, and Lake Charles, Louisiana.
About NAGE Niagen Bioscience Inc. Common Stock
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.